Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Specialty Generics Market?

Recent years have witnessed a swift expansion in the size of the specialty generics market. The market, projected to surge from $95.87 billion in 2024 to $108.11 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 12.8%. There are several contributing factors to the growth noted in the historical phase, including the expiration of patents for branded drugs, the escalating need for budget-friendly substitutes, regulations in place that support the approval of generic drugs, mounting pressure from rising healthcare costs, an increase in chronic illness cases, and the growth in the aging demographic.

What Growth Rate Is Forecasted for the Specialty Generics Market by 2029?

The market size for specialty generics is projected to experience a swift expansion in the upcoming years, reaching $189.72 billion in 2029 with a compound annual growth rate (CAGR) of 15.1%. The projected growth during the forecast period is due to factors such as the broadening of the biosimilars market, the focus on the development of complex generic drugs, the increased attention towards specialty generic injectables, the use of 3d printing in specialty generic production, and the burgeoning of specialty generics in emergent markets. Notable trends for the forecast duration include the customisation and targeting of specialty generics, the formation of strategic alliances and collaborations in generic drug advancement, the determination to create abuse-resistant formulations, the application of digital health technologies in specialty generics, and regulatory actions advocating for speedy approval of complex generics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

Which Key Companies Are Shaping the Future of the Specialty Generics Market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Which Factors Are Driving Demand in the Specialty Generics Industry?

The swell in long-term illnesses is anticipated to boost specialty generic market demand. Chronic diseases are enduring health conditions that can be challenging to cure, if not impossible. However, they can occasionally be treated and managed. The rise in these conditions is often due to changing lifestyles, dietary habits, and failure to maintain a healthy body weight. Moreover, some persistent chronic infections may even increase the risk of cancer. Rising instances of these diseases necessitate the use of specialty generic medicines to treat complex chronic conditions. For example, in September 2022, the World Health Organization, a Switzerland-based special agency under the auspices of the United Nations, reported that there are 41 million yearly global deaths due to non-communicable or chronic diseases, which represents 74% of all global deaths. These include 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. As a result, the rise in chronic diseases is leading to an increase in the growth of the specialty generic market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

How Is the Specialty Generics Market Segmented by Several Divisions?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

What are the Emerging Market Trends Driving the Growth of the Specialty Generics Industry?

Leading corporations in the specialty generic market, like Mallinckrodt plc, are obtaining necessary approvals like the one for Lisdexamfetamine Dimesylate to respond to urgent need for medications. Approvals in this sector refers to regulatory permissions granted for pharmaceutical goods which are biologically and therapeutically comparable to brand-name specialty drugs, normally employed for complex or rare medical conditions, post the expiration of their patent protection. For instance, in August 2023, Mallinckrodt plc, a specialty pharmaceutical corporation based in Ireland, got the FDA’s consent for their Lisdexamfetamine Dimesylate Capsules, under their SpecGx LLC Specialty Generics division, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic and a federally regulated substance (CII) used for ADHD and other conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Regions Are Driving Growth in the Specialty Generics Market?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

This Report Delivers Insight On:

1. How big is the specialty generics market, and how is it changing globally?

2. Who are the major companies in the specialty generics market, and how are they performing?

3. What are the key opportunities and risks in the specialty generics market right now?

4. Which products or customer segments are growing the most in the specialty generics market?

5. What factors are helping or slowing down the growth of the specialty generics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model